Vanguard Group Inc Jaguar Health, Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.08 - $809.55 $2,884 - $29.2 Million	-36,051 Reduced 2.28%	1,542,684 $138,000
Q3 2022 Nov 14, 2022	SELL	$0.17 - $765.0 $107,697 - $485 Million	-633,513 Reduced 28.64%	1,578,735 $246,000
Q2 2022 Aug 12, 2022	BUY	$0.27 - $0.71 $306,911 - $807,062	1,136,708 Added 105.69%	2,212,248 $651,000
Q1 2022 May 13, 2022	SELL	$0.38 - $1.07 $292,744 - $824,306	-770,380 Reduced 41.73%	1,075,540 $762,000
Q4 2021 Feb 14, 2022	SELL	$1.03 - $2.48 $2,468 - $5,944	-2,397 Reduced 0.13%	1,845,920 $1.92 Million
Q3 2021 Nov 12, 2021	BUY	$2.14 - $4.95 $3.96 Million - $9.15 Million	1,848,317 New	1,848,317 $4.2 Million

Ticker JAGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 119,861,000
Market Cap $125M
Description
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.